海昌生技 7814 Balance Sheet
26.45−0.15 (−0.56%)11/13 Close · Vol. 25 lots
—
—
Line items
Auto Read
Latest
Latest2026 Q3
海昌生技(7814)'s 2026 Q3 financial highlights: Total assets 456.0M · Debt ratio 4.3% · Equity 436.2M.
Total assets
456.0M
Debt ratio
4.3%
Equity
436.2M
About This Metric
Definition
Quarterly figures from the income statement, balance sheet and cash flow statement.
How to Read
Operating cash flow often reveals earnings quality better than reported net income.
Source
MOPS
Biotechnology and Medical Care
How much time do you spend wiring APIs, pulling data, and debugging — instead of thinking about strategy? Describe the signal, and Blave Agent researches and backtests it.
See what Blave Agent can do →